ZNF784 Inhibitors
ZNF784 inhibitors encompass a range of chemical compounds that target various signaling pathways which may indirectly influence the activity of the zinc finger protein ZNF784. For instance, PI3K inhibitors such as LY294002 and Wortmannin may impede the PI3K/AKT signaling axis, potentially affecting the regulatory mechanisms of ZNF784 if it is associated with this pathway. The inhibition of PI3K can lead to decreased AKT activation, which may play a role in the regulation of zinc finger proteins, thereby potentially inhibiting the function of ZNF784. Moreover, since mTOR is a critical component downstream of PI3K/AKT, rapamycin's ability to inhibit mTOR may also indirectly impact ZNF784, particularly if it is implicated in mTOR-regulated signaling processes.
Additionally, the MAPK/ERK pathway is a common conduit for modulating the activity of transcription factors, and MEK inhibitors like PD98059 and U0126 can dampen this signaling cascade. Reduced activity of the ERK pathway could affect the transcription regulatory functions of ZNF784. Similarly, SB203580 and SP600125 inhibit p38 MAPK and JNK, respectively, both of which are part of the broader MAPK pathway and can influence transcription factors. If ZNF784 is modulated by stress response signals through p38 or by other MAPK pathway components, these inhibitors could suppress its functional activity. Src family kinases and tyrosine kinase signaling, targeted by PP2 and dasatinib, play pivotal roles in various cellular processes, including the regulation of gene expression. The inhibition of these kinases could therefore impede any Src or tyrosine kinase-dependent modulation of ZNF784. Furthermore, the inhibition of protein kinase C by compounds such as GF109203X and Calphostin C may reduce the phosphorylation and thus the activity of ZNF784 if PKC is involved in its functional regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of PI3K, which is crucial for the activation of AKT signaling. ZNF784 function can be indirectly inhibited by this compound, as PI3K/AKT signaling may be involved in the regulation of DNA binding activity of zinc finger proteins like ZNF784. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which is a part of the MAPK/ERK pathway. By inhibiting MEK, PD98059 would reduce ERK phosphorylation, potentially affecting transcription factors like ZNF784 that are regulated by this signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which plays a role in stress response and is implicated in the modulation of various transcription factors. Inhibition of p38 MAPK could influence the activity of ZNF784 by altering its phosphorylation state or its interaction with co-regulators. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a selective inhibitor of JNK, part of the MAPK pathway responsible for the regulation of transcription factors. JNK inhibition can affect ZNF784 if it is involved in JNK-mediated gene expression regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible PI3K inhibitor. By inhibiting PI3K, it could lead to a decrease in AKT activation, and subsequently, affect the functional activity of ZNF784 if it relies on PI3K/AKT signaling for its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an inhibitor of mTOR, which is downstream of PI3K/AKT signaling. mTOR inhibition could decrease protein synthesis and indirectly affect ZNF784 if it is involved in pathways regulated by mTOR activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family kinases. If ZNF784 function is tied to Src kinase signaling, its activity may be indirectly inhibited through the prevention of Src-mediated phosphorylation events. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X is a potent inhibitor of protein kinase C (PKC). If ZNF784's activity is modulated through PKC-dependent signaling pathways, its function could be indirectly inhibited by GF109203X through the disruption of these pathways. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor. If ZNF784's function is mediated by tyrosine kinase signaling, its activity may be indirectly inhibited by dasatinib by precluding tyrosine kinase-dependent phosphorylation events. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Calphostin C inhibits PKC, which could lead to the modulation of transcription factors. If ZNF784's function is influenced by PKC signaling, Calphostin C could indirectly inhibit its activity by impeding PKC-dependent regulatory mechanisms. | ||||||